Key Facts

• One of Europe's fastest growing pharmaceutical companies
• 2007 sales totaling £45.5 MM GB
• Headquartered in Galashiels, Scotland
• United States office established in 2008
• Listed on the London Stock Exchange
  under the ticker PSK
• Areas of development include Women’s Health,
  Men’s Health, Metabolic Diseases, Cancer,
  Anesthesiology, and Cardiovascular Disease